Literature DB >> 24761616

[Identification of bufadienolides profiling in cinobufacino by HPLC-DAD-FT-ICR-MS method].

Jun-Qiu Liu, Nan Si, Jian Yang, Hai-Yu Zhao, Bao-Lin Bian, Hong-Jie Wang.   

Abstract

Cinobufacino injection is a significant anti-tumor medicine for the treatment of various tumors in clinic, which was made from water extraction of the skin of Bufo bufo gargarizans. In present paper, HPLC-DAD-FT-ICR-MS method was used to identify the major bufadienolides in cinobufacino for the first time. Solid-phase extraction with dichloromethane and silica was used to enrich the total bufadienolides in cinobufacino. Based on the UV and high resolution MS/MS data, 33 bufadienolides were analyzed and characterized. Among them, eight compounds were identified by comparing with standard references unambiguously. This study elucidated the major bufadienolides in cinobufacino, which provided material foundation of cinobufacino and will be benefit for the further pharmacological research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24761616

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  1 in total

1.  Evaluation of Bufadienolides as the Main Antitumor Components in Cinobufacin Injection for Liver and Gastric Cancer Therapy.

Authors:  Xiaolu Wei; Nan Si; Yuefei Zhang; Haiyu Zhao; Jian Yang; Hongjie Wang; Lianmei Wang; Linyu Han; Baolin Bian
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.